Gilead Sciences Stock Price and Value Analysis
Should you buy Gilead Sciences stock? (NasdaqGS:GILD). Let's see how it does in our automated value investing analysis system.
GILD Free Cash Flow Trend
Based on historical returns, we believe that Gilead Sciences can grow its free cash at a rate of about 8%. That's positive!
Inside the GILD Numbers
(Gilead Sciences stock price per share)
||GILD Fair Price
(based on intrinsic value)
||GILD Safety Price (based on a variable margin of safety)||$80.95|
||PE Ratio versus Sector||8% lower than other Healthcare stocks|
|PE Ratio versus Industry||67% lower than other Biotechnology stocks|
|Free Cash Flow Jitter||66%|
Is Gilead Sciences Stock on Sale?
We believe that Gilead Sciences may be worth examining further. It's making money, which is a very positive sign. Is it on sale?
Even better, Gilead Sciences looks like a stock on sale. Based on our analysis—if the company keeps making money the way it has been—you may be looking at a bargain. Keep this stock in mind as you put together your portfolio! See Before You Buy for your next steps (and read our disclaimer about investing risk).
Should You Buy GILD Stock?
Does Gilead Sciences have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.